CH625253A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625253A5 CH625253A5 CH1231476A CH1231476A CH625253A5 CH 625253 A5 CH625253 A5 CH 625253A5 CH 1231476 A CH1231476 A CH 1231476A CH 1231476 A CH1231476 A CH 1231476A CH 625253 A5 CH625253 A5 CH 625253A5
- Authority
- CH
- Switzerland
- Prior art keywords
- hydroxy
- oestran
- compounds
- formula
- steroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/618,176 US4004005A (en) | 1975-09-30 | 1975-09-30 | Steroidal erythropoietic agents and therapeutic compositions and methods |
| US05/693,249 US4049805A (en) | 1975-09-30 | 1976-06-04 | Steroidal erythropoietic agents and therapeutic compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625253A5 true CH625253A5 (fr) | 1981-09-15 |
Family
ID=27088168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1231476A CH625253A5 (fr) | 1975-09-30 | 1976-09-29 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4049805A (fr) |
| JP (1) | JPS5262263A (fr) |
| CH (1) | CH625253A5 (fr) |
| DE (1) | DE2643936A1 (fr) |
| DK (1) | DK145859C (fr) |
| FR (1) | FR2326198A1 (fr) |
| GB (1) | GB1565229A (fr) |
| IE (1) | IE43859B1 (fr) |
| LU (1) | LU75901A1 (fr) |
| NL (1) | NL7610812A (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372712B1 (en) | 1998-05-22 | 2002-04-16 | The Board Of Trustees Of The Leland Stanford Jr. University | Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand |
| US20040259803A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Disease prevention by reactivation of the thymus |
| US20040241842A1 (en) * | 1999-04-15 | 2004-12-02 | Monash University | Stimulation of thymus for vaccination development |
| US20050042679A1 (en) * | 1999-04-15 | 2005-02-24 | Monash University | Diagnostic indicator of thymic function |
| US20050020524A1 (en) * | 1999-04-15 | 2005-01-27 | Monash University | Hematopoietic stem cell gene therapy |
| AUPR074500A0 (en) * | 2000-10-13 | 2000-11-09 | Monash University | Treatment of t cell disorders |
| US20040265285A1 (en) * | 1999-04-15 | 2004-12-30 | Monash University | Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| US20040258672A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Graft acceptance through manipulation of thymic regeneration |
| US20060088512A1 (en) * | 2001-10-15 | 2006-04-27 | Monash University | Treatment of T cell disorders |
| CA2462681A1 (fr) * | 2000-10-13 | 2002-04-18 | Monash University | Prevention de maladies par reactivation du thymus |
| CA2450073C (fr) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique |
| US20080279812A1 (en) * | 2003-12-05 | 2008-11-13 | Norwood Immunology, Ltd. | Disease Prevention and Vaccination Prior to Thymic Reactivation |
| EP2671508B1 (fr) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Système pharma-informatique |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
-
1976
- 1976-06-04 US US05/693,249 patent/US4049805A/en not_active Expired - Lifetime
- 1976-09-20 IE IE2077/76A patent/IE43859B1/en unknown
- 1976-09-22 GB GB39299/76A patent/GB1565229A/en not_active Expired
- 1976-09-28 LU LU75901A patent/LU75901A1/xx unknown
- 1976-09-29 JP JP51117876A patent/JPS5262263A/ja active Pending
- 1976-09-29 DE DE19762643936 patent/DE2643936A1/de not_active Withdrawn
- 1976-09-29 DK DK437976A patent/DK145859C/da not_active IP Right Cessation
- 1976-09-29 CH CH1231476A patent/CH625253A5/de not_active IP Right Cessation
- 1976-09-30 FR FR7629388A patent/FR2326198A1/fr active Granted
- 1976-09-30 NL NL7610812A patent/NL7610812A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK437976A (da) | 1977-03-31 |
| IE43859B1 (en) | 1981-06-17 |
| US4049805A (en) | 1977-09-20 |
| DK145859C (da) | 1983-10-03 |
| FR2326198B1 (fr) | 1980-10-10 |
| IE43859L (en) | 1977-03-30 |
| GB1565229A (en) | 1980-04-16 |
| FR2326198A1 (fr) | 1977-04-29 |
| DK145859B (da) | 1983-03-21 |
| NL7610812A (nl) | 1977-04-01 |
| JPS5262263A (en) | 1977-05-23 |
| LU75901A1 (fr) | 1977-05-11 |
| DE2643936A1 (de) | 1977-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69133158T2 (de) | Behandlungsverfahren zur förderung des gewichtsverlustes unter verwendung eines substituierten delta-5-androstens | |
| DE2643936A1 (de) | Arzneimittel mit erythropoietischer wirksamkeit | |
| CH641352A5 (de) | 15-(hydroxy-, acyloxy- oder oxo-)steroide enthaltende mittel zur hemmung der biosynthese der mevalonsaeure. | |
| DE1801750A1 (de) | Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung | |
| DE2265138C3 (de) | Vincaminsäure-benzylester, dessen Salze mit Säuren, ein Verfahren zu ihrer Herstellung und pharmazeutische Mittel | |
| CH627761A5 (en) | Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone | |
| CH621560A5 (en) | Process for the preparation of 3-ketosteroids disubstituted in position 16 | |
| US4004005A (en) | Steroidal erythropoietic agents and therapeutic compositions and methods | |
| DE2624177A1 (de) | Verfahren zur herstellung von m-benzoylhydratropsaeure | |
| DE2515142B2 (de) | Oral verabfolgbare mittel zur senkung des lipid- und cholesterin- spiegels | |
| DE957030C (de) | Verfahren zur Herstellung der Phenylpropionsaeureester von Steroidhormonen | |
| DE1468919C (de) | 3,11 Dioxo steroid 4,9 diene und ein Verfahren zu ihrer Herstellung | |
| DE1668857C (de) | 6 alpha, 9 alpha Difluorprednisolon 17 valerat 21 acetat | |
| AT208526B (de) | Verfahren zur Herstellung von neuen Estern des Testosterons und 19-Nortestosterons | |
| EP0007347A1 (fr) | Dérivés de alkylène glycol abaissant le taux en lipide et procédés pour leur préparation. | |
| DE2307795C3 (de) | 11 beta 17alpha, 21 Trihydroxy-6 | |
| DE2145686C3 (de) | 2-Chlor-S-sulfamylbenzoesäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten | |
| DE965637C (de) | Verfahren zur Herstellung von 19-Nortestosteron-17-acylaten und bzw. oder deren 3-Enolacylaten | |
| DE912695C (de) | Verfahren zur Herstellung eines Oestradiolesters | |
| DE1493107C3 (de) | 13-Äthyl-17 a-Äthinylgon-5-en- 3 ß, 17beta diolester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE2344749A1 (de) | Arzneimittel auf basis von androst3-en-17-ol und seinen estern | |
| DE1668857B1 (de) | 6alpha,9alpha-Difluorprednisolon-17-valerat-21-acetat | |
| DE1102145B (de) | Verfahren zur Herstellung von therapeutisch wirksamen Monoacylaten des Pregnan- bzw.Allopregnan-3ª‰, 16ª‡-diol-20-ons | |
| DE1107225B (de) | Verfahren zur Herstellung von 1, 4, 17(20)-Pregnatrienen | |
| DE1048273B (de) | Verfahren zur Herstellung von anabolisch wirksamen 17ª‡-Alkyl-5ª‡(oder 5ª‰)-androstanoder 19-nor-androstan)-3,11ª‰,17ª‰-triolen und dessen Acylaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |